학술논문
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Document Type
Article
Author
Orkin, Chloe; DeJesus, Edwin; Sax, Paul E; Arribas, Jose R; Gupta, Samir K; Martorell, Claudia; Stephens, Jeffrey L; Stellbrink, Hans-Jurgen; Wohl, David; Maggiolo, Franco; Thompson, Melanie A; Podzamczer, Daniel; Hagins, Debbie; Flamm, Jason A; Brinson, Cynthia; Clarke, Amanda; Huang, Hailin; Acosta, Rima; Brainard, Diana M; Collins, Sean E ; Martin, Hal
Source
In The Lancet HIV June 2020 7(6):e389-e400
Subject
Language
ISSN
2352-3018